
The biotech industry is primed for robust expansion, owing to increased investments in research and development, incorporation of advanced technologies, and growing demand for personalized medicine.
Given this backdrop, fundamentally strong biotech stocks Dynavax Technologies Corporation (DVAX), Entrada Therapeutics, Inc. (TRDA), and Shionogi & Co., Ltd. (SGIOY), trading under $15, could be solid buys now.